Neuroinflammatory processes in Alzheimer’s disease

Heneka, Michael T., O’Banion, M. Kerry, Terwel, Dick, Kummer, Markus Peter·2010·Journal of Neural Transmission

Cited by (432)

Items 201–300 of 432

  1. Small Heat Shock Proteins Induce a Cerebral Inflammatory Reaction
    Ilona B. Bruinsma, Mieke de Jager, Anna Carrano, Alexandra A. M. Versleijen, Robert Veerhuis, Wilbert C. Boelens, Annemieke J.M. Rozemüller, Robert M.W. de Waal, Marcel M. Verbeek · 2011 · Journal of Neuroscience
  2. Alzheimer's Disease—Current Status and Future Directions
    Deepshikha Bhardwaj, Connie Mitra, Chandrakala Aluganti Narasimhulu, Aladdin Riad, Mitsushita Doomra, Sampath Parthasarathy · 2017 · Journal of Medicinal Food
  3. Quercetin ameliorates inflammation in CA1 hippocampal region in aged triple transgenic Alzheimer´s disease mice model.
    Felipe Vargas-Restrepo, Angélica María Sabogal-Guáqueta, Gloria Patricia Cardona‐Gómez · 2017 · Biomédica
  4. Chronic Anatabine Treatment Reduces Alzheimer’s Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD
    Megha Verma, David Beaulieu‐Abdelahad, Ghania Ait‐Ghezala, Rena Li, Fiona Crawford, MICHAEL J. MULLAN, Daniel Paris · 2015 · PLoS ONE
  5. Correction: Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine
    Manuel van Gijsel‐Bonnello, Kévin Baranger, Philippe D. Benech, Santiago Rivera, Michel Khrestchatisky, Max L. De Reggi, Bouchra Gharib · 2018 · PLoS ONE
  6. Clinical Benefits of Antioxidative Supplement Twendee X for Mild Cognitive Impairment: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Prospective Interventional Study
    Tadokoro, Koh, Morihara, Ryuta, Ohta, Yasuyuki, Hishikawa, Nozomi, Kawano, Satoko, Sasaki, Ryo, Matsumoto, Namiko, Nomura, Emi, Nakano, Yumiko, Takahashi, Yoshiaki et al. · 2019 · Journal of Alzheimer s Disease
  7. Combined effects of aerobic exercise and 40-Hz light flicker exposure on early cognitive impairments in Alzheimer’s disease of 3×Tg mice
    Sang-Seo Park, Hye-Sang Park, Chang‐Ju Kim, Seung‐Soo Baek, Song‐Young Park, Cody Anderson, Myung-Ki Kim, Ik-Ryeul Park, Tae-Woon Kim · 2022 · Journal of Applied Physiology
  8. Serum neurofilament light chain and inflammatory cytokines as biomarkers for early detection of mild cognitive impairment
    Xinyang Jing, Lan Wang, Mei Ling Song, Hao Geng, Wei Li, Yaoyang Huo, Anqi Huang, Xueyi Wang, Cuixia An · 2024 · Scientific Reports
  9. Fibrillar β‐amyloid 1‐42 alters cytokine secretion, cholinergic signalling and neuronal differentiation
    Linn Malmsten, Swetha Vijayaraghavan, Outi Hovatta, Amelia Marutle, Taher Darreh‐Shori · 2014 · Journal of Cellular and Molecular Medicine
  10. Tocilizumab’s effect on cognitive deficits induced by intracerebroventricular administration of streptozotocin in Alzheimer’s model
    Hatice Kübra Elçioğlu, Ersin Aslan, Sarfraz Ahmad, Saadet Alan, Emine Şalva, Ö. Haluk Elcioglu, Levent Kabasakal · 2016 · Molecular and Cellular Biochemistry
  11. The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging
    Theodore A. Henderson · 2012 · CNS Spectrums
  12. Flavonoid-rich ethanol extract from the leaves of Diospyros kaki attenuates cognitive deficits, amyloid-beta production, oxidative stress, and neuroinflammation in APP/PS1 transgenic mice
    Yingjuan Ma, Bin Ma, Yuying Shang, Qingqing Yin, Hong Yan, Song Xu, Chao Shen, Xunyao Hou, Xueping Liu · 2017 · Brain Research
  13. Visualization of Altered Hippocampal Connectivity in an Animal Model of Alzheimer’s Disease
    Seong Gak Jeon, Yong Jun Kim, Kyoung Ah Kim, Inhee Mook‐Jung, Minho Moon · 2018 · Molecular Neurobiology
  14. First-in-class DAPK1/CSF1R dual inhibitors: Discovery of 3,5-dimethoxy-N-(4-(4-methoxyphenoxy)-2-((6-morpholinopyridin-3-yl)amino)pyrimidin-5-yl)benzamide as a potential anti-tauopathies agent
    Ahmed Karam Farag, Ahmed H.E. Hassan, Hyeanjeong Jeong, Youngji Kwon, Jin Gyu Choi, Myung Sook Oh, Ki Duk Park, Yun Kyung Kim, Eun Joo Roh · 2018 · European Journal of Medicinal Chemistry
  15. The hippocampus associated GABAergic neural network impairment in early-stage of Alzheimer's disease
    Yuanhong Tang, Yan Yan, Jian Mao, Junjun Ni, Hong Qing · 2023 · Ageing Research Reviews
  16. Effects of aging on the motor, cognitive and affective behaviors, neuroimmune responses and hippocampal gene expression
    Gaurav Singhal, Julie Morgan, Magdalene C. Jawahar, Frances Corrigan, Emily Joy Jaehne, Catherine G. Toben, James Breen, Stephen Pederson, Jim Manavis, Anthony John Hannan et al. · 2020 · Behavioural Brain Research
  17. Potential of chromatin modifying compounds for the treatment of Alzheimer's disease
    Tom C. Karagiannis, Katherine Ververis · 2012 · Pathobiology of Aging & Age-related Diseases
  18. Chromogranin peptides in brain diseases
    Michael Willis, Irmgard Leitner, K. A. Jellinger, Josef Marksteiner · 2011 · Journal of Neural Transmission
  19. Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer’s disease mouse models
    Micha M.M. Wilhelmus, Mieke de Jager, August Benjamin Smit, Rolinka J. van der Loo, Benjamin Drukarch · 2016 · Scientific Reports
  20. Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study
    Wagner F. Gattaz, Leda Leme Talib, Evelin Lisete Schaeffer, Breno Satler Diniz, Orestes Vicente Forlenza · 2013 · Journal of Neural Transmission
  21. The MMP-2/TIMP-2 System in Alzheimer Disease
    Hongyue Wang, Longjian Huang, Lei Wu, Jiaqi Lan, Xinhong Feng, Pingping Li, Ying Peng · 2020 · CNS & Neurological Disorders - Drug Targets
  22. HMG-CoA Reductase Inhibitors Attenuate Neuronal Damage by Suppressing Oxygen Glucose Deprivation-Induced Activated Microglial Cells
    Dan Lu, Lingling Shen, Hongcheng Mai, Jiankun Zang, Yanfang Liu, Chi Kwan Tsang, Keshen Li, Anding Xu · 2019 · Neural Plasticity
  23. An apolipoprotein E4 fragment affects matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and cytokine levels in brain cell lines
    Dafnis, I., Tzinia, A.K., Tsilibary, E.C., Zannis, V.I., Chroni, A. · 2012 · Neuroscience
  24. Alzheimer’s Disease, Astrocytes and Kynurenines
    Lívia Dézsi, Bernadett Tuka, Diána Martos, László Vécsei · 2015 · Current Alzheimer Research
  25. The hydrogen sulfide releasing compounds ATB-346 and diallyl trisulfide attenuate streptozotocin-induced cognitive impairment, neuroinflammation, and oxidative stress in rats: involvement of asymmetric dimethylarginine
    Dalia Kamal Mostafa, Nesrine M. El Azhary, Rasha A. Nassra · 2016 · Canadian Journal of Physiology and Pharmacology
  26. Neuroinflammation and β Amyloid Deposition in Alzheimer's Disease: In vivo Quantification with Molecular Imaging
    Caroline Hommet, Karl Mondon, Vincent Camus, Maria João Ribeiro, Émilie Beaufils, Nicolas Arlicot, Philippe Corcia, Marc Paccalin, Frédéric Minier, Thomas Gosselin et al. · 2013 · Dementia and Geriatric Cognitive Disorders
  27. Alzheimer’s disease: The role of T lymphocytes in neuroinflammation and neurodegeneration
    Moses Oluwasegun Asamu, Oladapo O. Oladipo, Oluseun A. Abayomi, Afeez A. Adebayo · 2023 · Brain Research
  28. Brain-derived neurotrophic factor expression ex vivo in obesity
    Chun‐Jung Huang, David C. Mari, MICHAEL A. WHITEHURST, Aaron L. Slusher, Alan Wilson, Yoshimi Shibata · 2013 · Physiology & Behavior
  29. Antagonism of NF-κB-up-regulated micro RNAs (miRNAs) in sporadic Alzheimer's disease (AD)—anti-NF-κB vs. anti-miRNA strategies
    Walter J. Lukiw · 2013 · Frontiers in Genetics
  30. Nicotinic Acetylcholine Receptors and Microglia as Therapeutic and Imaging Targets in Alzheimer’s Disease
    Kazuyuki Takata, Hiroyuki Kimura, Daijiro Yanagisawa, Koki Harada, Kaneyasu Nishimura, Yoshihisa Kitamura, Shun Shimohama, Ikuo Tooyama · 2022 · Molecules
  31. Glia Maturation Factor Expression in Hippocampus of Human Alzheimer’s Disease
    Deirdre A. Stolmeier, Ramasamy Thangavel, Poojya Anantharam, Mohammad Moshahid Khan, Duraisamy Kempuraj, Asgar Zaheer · 2013 · Neurochemical Research
  32. Differential effects of duration and age on the consequences of neuroinflammation in the hippocampus
    Isabelle Bardou, Holly M. Brothers, Roxanne M. Kaercher, Sarah C. Hopp, Gary L. Wenk · 2013 · Neurobiology of Aging
  33. Patchouli alcohol ameliorates the learning and memory impairments in an animal model of Alzheimer's disease via modulating SIRT1
    Qingqing Xu, Ziren Su, Zhen Jie Hu, Wen Yang, Yan‐Fang Xian, Zhi‐Xiu Lin · 2022 · Phytomedicine
  34. Cellular connections, microenvironment and brain angiogenesis in diabetes: Lost communication signals in the post-stroke period
    Adviye Ergul, John Paul Valenzuela, Abdelrahman Y. Fouda, Susan C. Fagan · 2015 · Brain Research
  35. New Approaches in the Design and Development of Cannabinoid Receptor Ligands: Multifunctional and Bivalent Compounds
    Martin Nimczick, Michael W. Decker · 2015 · ChemMedChem
  36. Selective induction of alternatively spliced FynT isoform by TNF facilitates persistent inflammatory responses in astrocytes
    Chingli Lee, Clara Y. B. Low, Siew Ying Wong, Mitchell K.P. Lai, Michelle G. K. Tan · 2017 · Scientific Reports
  37. Chromogranin A in the early steps of the neurosecretory pathway
    Fanny Laguerre, Youssef Anouar, Maïté Montero‐Hadjadje · 2019 · IUBMB Life
  38. Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer’s Disease (Type 3 Diabetes)
    Suzanne M. de la Monte · 2023 · Journal of Alzheimer s Disease
  39. The antimicrobial protein, CAP37, is upregulated in pyramidal neurons during Alzheimer’s disease
    Amanda J. Brock, Anne Kasus‐Jacobi, Megan R. Lerner, Sreemathi Logan, Adekunle M. Adesina, Heloise Anne Pereira · 2015 · Histochemistry and Cell Biology
  40. The endogenous α7 nicotinic acetylcholine receptor antagonist kynurenic acid modulates amyloid-β-induced inflammation in BV-2 microglial cells
    Levke Steiner, Maike Gold, David Mengel, Richard C. Dodel, Jan‐Philipp Bach · 2014 · Journal of the Neurological Sciences
  41. MFG-E8 inhibits Aβ-induced microglial production of cathelicidin-related antimicrobial peptide: A suitable target against Alzheimer’s disease
    Xiaotian Xu, Xiaoying Cai, Yingting Zhu, Wen He, Qi Wu, Xiaolei Shi, Yannan Fang, Zhong Pei · 2018 · Cellular Immunology
  42. Nitric Oxide Decreases the Enzymatic Activity of Insulin Degrading Enzyme in APP/PS1 Mice
    Markus P. Kummer, Claudia Hülsmann, Michael Hermes, Daisy Axt, Michael Thomas Heneka · 2012 · Journal of Neuroimmune Pharmacology
  43. Effects of systemic Thalidomide and intracerebroventricular Etanercept and Infliximab administration in a Streptozotocin induced dementia model in rats
    Hatice Kübra Elçioğlu, Levent Kabasakal, Fatih Tufan, Ö. Haluk Elcioglu, Seyhun Solakoğlu, Tuğba Kotil, Mehmet Akif Karan · 2015 · Acta Histochemica
  44. Anti-inflammatory (M2) macrophage media reduce transmission of oligomeric amyloid beta in differentiated SH-SY5Y cells
    Valerie Sackmann, Anna Ansell, Christopher Sackmann, Harald Lund, Robert Adam Harris, Martin Hallbeck, Camilla Nilsberth · 2017 · Neurobiology of Aging
  45. Role of Scavenger Receptors in Glia-Mediated Neuroinflammatory Response Associated with Alzheimer’s Disease
    Francisca Cornejo, Rommy von Bernhardi M. · 2013 · Mediators of Inflammation
  46. N-3 PUFA diet enrichment prevents amyloid beta-induced depressive-like phenotype
    Maria Grazia Morgese, Stefania Schiavone, Emanuela Mhillaj, María Bové, Paolo Tucci, Luigia Trabace · 2017 · Pharmacological Research
  47. Interleukin 22 and its association with neurodegenerative disease activity
    Wenjian Chen, Jianpeng Wang, Huaizhi Yang, Yuankai Sun, Bangjie Chen, Yuchen Liu, Yanxun Han, Ming Shan, Junfeng Zhan · 2022 · Frontiers in Pharmacology
  48. Free Gangliosides Can Alter Amyloid-β Aggregation
    Arghya Chakravorty, Samuel D. McCalpin, Bikash Ranjan Sahoo, Ayyalusamy Ramamoorthy, Charles L. Brooks · 2022 · The Journal of Physical Chemistry Letters
  49. Regulation of neuroinflammation in Alzheimer's disease via nanoparticle-loaded phytocompounds with anti-inflammatory and autophagy-inducing properties
    Vinayak Nayak, Sushmita Patra, Shrushti Rout, Atala Bihari Jena, Rohit Sharma, Kali Prasad Pattanaik, Jay Singh, Shyam Sunder Pandey, Ravindra Pratap Singh, Sanatan Majhi et al. · 2023 · Phytomedicine
  50. Characterization of the role of the antioxidant proteins metallothioneins 1 and 2 in an animal model of Alzheimer’s disease
    Yasmina Manso, Javier Carrasco, Gemma Comes, Paul Anthony Adlard, Ashley Ian Bush, Juan Hidalgo · 2012 · Cellular and Molecular Life Sciences
  51. Microglial TREM2 Mitigates Inflammatory Responses and Neuronal Apoptosis in Angiotensin II-Induced Hypertension in Middle-Aged Mice
    Xiaotian Xu, Lin Du, Jianxiong Jiang, Ming Yang, Zhaoxia Wang, Yingge Wang, Tieyu Tang, Xuetao Fu, Jiukuan Hao · 2021 · Frontiers in Aging Neuroscience
  52. Research progress of the CXCR4 mechanism in Alzheimer's disease
    Qiulin Wang, Chang‐Le Fang, Xueyan Huang, Lu‐Lu Xue · 2022 · Ibrain
  53. The mitochondrial aspartate/glutamate carrier isoform 1 gene expression is regulated by CREB in neuronal cells
    Alessio Menga, Vito Iacobazzi, Vittoria Infantino, Maria Laura Avantaggiati, Ferdinando Palmieri · 2015 · The International Journal of Biochemistry & Cell Biology
  54. Neuroprotective Effects of Amylin Analogues on Alzheimer’s Disease Pathogenesis and Cognition
    John Grizzanti, Rachel R. Corrigan, Gemma Casadesús · 2018 · Journal of Alzheimer s Disease
  55. Protective Effect of Hyperforin on β Amyloid Protein Induced Apoptosis in PC12 Cells and Colchicine Induced Alzheimer’s Disease: An Anti-oxidant and Anti-inflammatory Therapy
    Jiang Xu, Mukesh Kumar, Yonglin Zhu · 2018 · Journal of Oleo Science
  56. The association of astrogliosis and microglial activation with aging and Alzheimer’s disease pathology in the chimpanzee brain.
    Edler, Melissa K., Munger, Emily L., Maycon, Hannah, Hopkins, William D., Hof, Patrick R., Sherwood, Chet C., Raghanti, Mary Ann · 2023 · Journal of Neuroscience Research
  57. N-3 polyunsaturated fatty acid and neuroinflammation in aging and Alzheimer's disease
    Sophie Layé, Charlotte Madore, Isabelle St‐Amour, Jean-Christophe Delpech, Corinne Joffre, Agnès Nadjar, Frédéric Calon · 2015 · Nutrition and Aging
  58. Evaluation of inflammation-related genes polymorphisms in Mexican with Alzheimer’s disease: a pilot study
    Danira Toral-Ríos, Diana Franco-Bocanegra, Óscar Rosas‐Carrasco, Francisco Mena‐Barranco, Rosa Carvajal-García, Marco Antonio Meraz‐Ríos, Victoria Campos‐Peña · 2015 · Frontiers in Cellular Neuroscience
  59. Central and Peripheral Inflammation in Mild Cognitive Impairment in the Context of Alzheimer’s Disease
    Inès Schmidt-Morgenroth, Philippe Michaud, Fabrizio Gasparini, Alexandre Avraméas · 2023 · International Journal of Molecular Sciences
  60. Comparative Insight into Microglia/Macrophages-Associated Pathways in Glioblastoma and Alzheimer’s Disease
    Jian Shi, Shi‐Wei Huang · 2023 · International Journal of Molecular Sciences
  61. Increased levels of MIP-1 α in CSF and serum of ALS
    Xi Yang, L. Gao, Xing Wu, Y. Zhang, Dawei Zang · 2015 · Acta Neurologica Scandinavica
  62. Therapeutic implications of glycogen synthase kinase-3β in Alzheimer’s disease: a novel therapeutic target
    Deepa S. Mandlik, Satish K. Mandlik, S. Arulmozhi · 2022 · International Journal of Neuroscience
  63. An Optimized Combination of Ginger and Peony Root Effectively Inhibits Amyloid-β Accumulation and Amyloid-β-Mediated Pathology in AβPP/PS1 Double-Transgenic Mice
    Soonmin Lim, Jin Gyu Choi, Minho Moon, Hyo Geun Kim, Wonil Lee, Hyoung-rok Bak, Ha-Chang Sung, Chi Hye Park, Sun Yeou Kim, Myung Sook Oh · 2016 · Journal of Alzheimer s Disease
  64. N-3 PUFA Prevent Oxidative Stress in a Rat Model of Beta-Amyloid-Induced Toxicity
    Maria Grazia Morgese, Stefania Schiavone, María Bové, Anna Laura Colia, Stefania Dimonte, Paolo Tucci, Luigia Trabace · 2021 · Pharmaceuticals
  65. Association of cholinergic basal forebrain volume and functional connectivity with markers of inflammatory response in the Alzheimer’s disease spectrum
    Teipel, Stefan J., Dyrba, Martin, Ballarini, Tommaso, Brosseron, Frederic, Bruno, Davide, Buerger, Katharina, Cosma, Nicoleta-Carmen, Dechent, Peter, Dobisch, Laura, Düzel, Emrah et al. · 2022 · Journal of Alzheimer s Disease
  66. Small Heat Shock Protein 22 Improves Cognition and Learning in the Tauopathic Brain
    Santiago Rodriguez Ospina, Danielle M. Blazier, Marangelie Criado‐Marrero, Lauren A. Gould, Niat T. Gebru, David Beaulieu‐Abdelahad, Xinming Wang, Elizabeth R. Remily-Wood, Dale Chaput, Stanley M. Stevens et al. · 2022 · International Journal of Molecular Sciences
  67. Ankle-Brachial Index but Neither Intima Media Thickness Nor Coronary Artery Calcification is Associated With Mild Cognitive Impairment
    Christian Weimar, on behalf the Heinz Nixdorf Recall Study Investigative Group, Angela Winkler, Martha Jokisch, Nils Lehmann, Frauke Hennig, Marcus Bauer, Knut Kröger, Hagen Kälsch, Amir Abbas Mahabadi et al. · 2015 · Journal of Alzheimer s Disease
  68. “Olfactory Three-Needle” Enhances Spatial Learning and Memory Ability in SAMP8 Mice
    Yuan Wang, Qiang Wang, Bo Xu Ren, Ting Guo, Jing Qiang, Hui Cao, Yujie Gao, Zhibin Liu, Xinyan Gao, Bing Zhu · 2020 · Behavioural Neurology
  69. A Systematic Review of Current Progresses in the Nucleic Acid-Based Therapies for Neurodegeneration with Implications for Alzheimer’s Disease
    Maryam Selk Ghaffari, Nima Sanadgol, Mohammad Reza Abdollahi · 2020 · Mini-Reviews in Medicinal Chemistry
  70. β‐amyloid context intensifies vascular smooth muscle cells induced inflammatory response and de‐differentiation
    Amélie Vromman, Nesrine Trabelsi, Clotilde Rouxel, Gilbert Bereziat, Isabelle Limon, Régis Blaise · 2013 · Aging Cell
  71. The Role of Astrocytes and Blood–Brain Barrier Disruption in Alzheimer’s Disease
    J. V. R. Cruz, C. Batista, L. Diniz, F. Mendes · 2023 · Neuroglia
  72. Synthesis and neuroprotective activity of novel 1,2,4-triazine derivatives with ethyl acetate moiety against H 2 O2 and Aβ-induced neurotoxicity
    Tuba Tüylü Küçükkılınç, Kamaledin Safari Yanghagh, Beyza Ayazgök, Mohammad Ali Roknipour, Farshad Homayouni Moghadam, Alireza Moradi, Saeed Emami, Mohsen Amini, Hamid Irannejad · 2017 · Medicinal Chemistry Research
  73. Recent Understanding of the Molecular Mechanisms of Alzheimer?s Disease
    Marcus O.W. Grimm, Tobias Hartmann · 2011 · Journal of Addiction Research & Therapy
  74. Role of astrocyte in neuroinflammation‐induced loss in neuroplasticity and subsequent onset of depression: A systematic review
    Gaurav Singhal, Saurabh Singhal, Bernhard Theodor Baune · 2025 · Neuroprotection/Neuroprotection (Chichester, England. Print)
  75. Metallothioneins in Prion- and Amyloid-Related Diseases
    Pavlína Adam, Soňa Křížková, Zbyněk Heger, Petr Babula, Vladimír Pekařík, Markéta Vaculovičová, Cláudio M. Gomes, René Kizek, Vojtěch Adam · 2016 · Journal of Alzheimer s Disease
  76. Ginsenoside Rd protects transgenic Caenorhabditis elegans from β-amyloid toxicity by activating oxidative resistant
    Lihan Mi, Meiling Fan, Tianjia Liu, Donglu Wu, Yang Wang, Fuqiang Li, Yong Cai, Zhidong Qiu, Da Liu, Lingling Cao · 2022 · Frontiers in Pharmacology
  77. Inhibitory effect of a 2,4-bis(4-hydroxyphenyl)-2-butenal diacetate on neuro-inflammatory reactions via inhibition of STAT1 and STAT3 activation in cultured astrocytes and microglial BV-2 cells
    Jin A Kim, Hyung‐Mun Yun, Peng Jin, Hee Pom Lee, Jin Yi Han, Venkatareddy Udumula, Dong Cheul Moon, Sang‐Bae Han, Ki Wan Oh, Young Wan Ham et al. · 2013 · Neuropharmacology
  78. Death-associated protein kinase 1 mediates interleukin-1β production through regulating inlfammasome activation in Bv2 microglial cells and mice
    Limin Song, Lei Pei, Lisha Hu, Shangwen Pan, Wei Xiong, Min Liu, Yan Wu, You Shang, Shanglong Yao · 2018 · Scientific Reports
  79. Protein kinase C eta is activated in reactive astrocytes of an Alzheimer's disease mouse model: Evidence for its immunoregulatory function in primary astrocytes
    Amitha Muraleedharan, Noa Rotem‐Dai, Itai Strominger, Nikhil Ponnoor Anto, Noah Isakov, Alon Monsonego, Etta Livneh · 2020 · Glia
  80. Neuroprotective effects of carbenoxolone against amyloid-beta 1–42 oligomer-induced neuroinflammation and cognitive decline in rats
    Sheetal Sharma, Avneet Saini, Bimla Nehru · 2021 · NeuroToxicology
  81. Inducible nitric oxide inhibitor aminoguanidine, ameliorated oxidative stress, interleukin-6 concentration and improved brain-derived neurotrophic factor in the brain tissues of neonates born from titanium dioxide nanoparticles exposed rats
    Amir Asghari, Mahmoud Hosseini, Farimah Beheshti, Mohammad Naser Shafei, Soghra Mehri · 2018 · The Journal of Maternal-Fetal & Neonatal Medicine
  82. Effect of Colloidal Aqueous Solution of Fullerene (C60) in the Presence of a P-Glycoprotein Inhibitor (Verapamil) on Spatial Memory and Hippocampal Expression of Sirtuin6, SELADIN1, and AQP1 Genes in a Rat Model of Alzheimer’s Disease
    Mehrnoosh Nikpour, Ali Sharafi, Mehrdad Hamidi, Sina Andalib · 2020 · ACS Chemical Neuroscience
  83. Targeting Abnormal PI3K/AKT/mTOR Signaling in Intracerebral Hemorrhage: A Systematic Review on Potential Drug Targets and Influences of Signaling Modulators on Other Neurological Disorders
    Sidharth Mehan, Kuldeep Singh Jadaun, Aarti Sharma, Ehraz Mehmood Siddiqui · 2021 · Current Clinical Pharmacology
  84. Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer’s Disease
    Ongali, Brice, Nicolakakis, Nektaria, Tong, Xing-Kang, Aboulkassim, Tahar, Imboden, Hans, Hamel, Edith · 2016 · Journal of Alzheimer’s Disease
  85. The Beneficial Effect of Physical Exercise on Inflammatory Makers in Older Individuals
    Pablo Gómez-Rubio, Isabel Trapero · 2020 · Endocrine Metabolic & Immune Disorders - Drug Targets
  86. Roles of Cannabidiol in the Treatment and Prevention of Alzheimer’s Disease by Multi-target Actions
    Xiao- Bei Zhang, Jintao Li, Juan-Hua Gu, Yue-Qin Zeng · 2021 · Mini-Reviews in Medicinal Chemistry
  87. Multimechanism biological profiling of tetrahydro-β-carboline analogues as selective HDAC6 inhibitors for the treatment of Alzheimer's disease
    Ting Liang, Shiru Liu, Baiyun Dang, Xiaofa Luan, Yifan Guo, Raphael R. Steimbach, Jiadong Hu, Long Lu, Peiyu Yue, Ruotian Wang et al. · 2024 · European Journal of Medicinal Chemistry
  88. Thalidomide attenuates learning and memory deficits induced by intracerebroventricular administration of streptozotocin in rats
    HK Elçioğlu, Levent Kabasakal, Saadet Alan, Emine Şalva, Fatih Tufan, M.A. Karan · 2012 · Biotechnic & Histochemistry
  89. Inflammatory Chemokines Expression Variations and Their Receptors in APP/PS1 Mice
    Adrián Jorda, Martı́n Aldasoro, Constanza Aldasoro, Soraya L. Vallés · 2021 · Journal of Alzheimer s Disease
  90. One immune cell to bind them all: platelet contribution to neurodegenerative disease
    Gabriela Rodriguez Moore, Isabel Melo-Escobar, David Stegner, Oliver Bracko · 2024 · Molecular Neurodegeneration
  91. Peripheral Vitamin C Levels in Alzheimer’s Disease: A Cross-Sectional Study
    Kazuki Ide, Hiroshi Yamada, Yohei Kawasaki, Mie Yamanaka, Nobuko Kawakami, Yusuke Katsuyama, Hidefumi Yoshida, Kang Kim, Emi Shiosaki, Akihiro Sonoda et al. · 2016 · Journal of Nutritional Science and Vitaminology
  92. Alteraciones en la corteza motora primaria en la enfermedad de Alzheimer: estudio en el modelo 3xTg-AD
    Erika Orta‐Salazar, Alfredo Feria‐Velasco, Sofía Y. Díaz-Cintra · 2017 · Neurología
  93. The Use of Polyphenols for the Treatment of Alzheimer’s Disease
    Sethuraman Sathya, Kasi Pandima Devi · 2018 · Elsevier eBooks
  94. Depression and Mild Cognitive Impairment in the General Population: Results of the Heinz Nixdorf Recall Study
    Martha Jokisch, on behalf of the Heinz Nixdorf Recall Study Investigative Group, Angela Winkler, Nico Dragano, Susanne Moebus, Karl‐Heinz Jöckel, Raimund M. Erbel, Christian Weimar · 2015 · Journal of Alzheimer s Disease
  95. γ-Secretase Inhibition of Murine Choroidal Neovascularization Is Associated with Reduction of Superoxide and Proinflammatory Cytokines
    Xiaoping Qi, Jun Cai, Qing Ruan, Li Liu, Sanford L. Boye, Zhijuan Chen, William W. Hauswirth, Renee C. Ryals, Lynn C. Shaw, Sergio Caballero et al. · 2011 · Investigative Ophthalmology & Visual Science
  96. STC1 ameliorates cognitive impairment and neuroinflammation of Alzheimer’s disease mice via inhibition of ERK1/2 pathway
    Pu Wang, Xiao-Long Li, Zhihua Cao · 2021 · Immunobiology
  97. Accelerated axon loss in MOG35-55 experimental autoimmune encephalomyelitis (EAE) in myelin-associated glycoprotein-deficient (MAGKO) mice
    Melina Jones, Thien T. Nguyen, Osefame Ewaleifoh, Lori A. Lebson, Katherine A. Whartenby, John Wesley Griffin, Peter A. Calabresi · 2013 · Journal of Neuroimmunology
  98. Liver Growth Factor “LGF” as a Therapeutic Agent for Alzheimer’s Disease
    Rafael Gonzalo‐Gobernado, Juan Perucho, Manuela Vallejo-Muñoz, Marı́a José Casarejos, Diana Reimers, Adriano Jiménez‐Escrig, Ana Gómez, Gonzalo M. Ulzurrun de Asanza, Eulalia Bazán · 2020 · International Journal of Molecular Sciences
  99. Differences in the frequency of Alzheimer's disease‐associated genomic variations in populations of different races
    Po-Yin Samuel Huang, Sun‐Wung Hsieh, Ya‐Hsuan Chang, Ai‐Ling Hour, Hsuan‐Yu Chen, Ching‐Kuan Liu · 2017 · Geriatrics and gerontology international/Geriatrics & gerontology international
  100. Anti-neuroinflammatory effects of SLOH in Aβ-induced BV-2 microglial cells and 3xTg-AD mice involve the inhibition of GSK-3β
    Xiaoli Wu, Jayasankar Kosaraju, Kin Yip Tam · 2018 · Neuroscience Letters